How researchers have expanded COVID-19 vaccine studies to include kids. Dr. Widermann is the PI for the Pfizer-BioNTech COVID-19 vaccine for children 6 months - 11 years of age. 

Are you an in the informatics field? Read about strategies and lessons learned from informatics experts in the Center for Leading Innovation and Collaboration’s blog post. Then check out webcasts 5-12 in the Insights to Inspire series!

Now accepting applications for the 2022-2023 Academic Year! The Global Health Initiative at Childrens National Hospital seeks to foster and encourage the development of research that addresses key pediatric global health challenges, improves health outcomes in resource-limited settings, and favorably positions faculty to obtain extramural funding in pediatric global health research. Projects to be considered must be conducted in a low or middle-income country (LMIC) on a pediatric topic of importance to that country and/or have direct relevance to emerging global threats. Proposals to study a health issue in a developing country that could be studied using a US population are not encouraged and will receive a lower score.

MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development.

There is a critical need for investigators prepared to conduct clinical and translational research in myasthenia gravis (MG). The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.

"Re-engineering the Clinical Research Enterprise in Response to COVID-19: The CTSA Experience" 
The COVID-19 pandemic has been one of the greatest global public health crises of our lifetime. Across the country, institutions in the CTSA Program responded quickly to it, pivoting research and creating new programs to respond to the outbreak. This special theme issue of the Journal of Clinical and Translational Science (JCTS) reflects on these changes, shares lessons learned and discusses which practices can continue in the future to advance translational science.

Are you interested in translational science? Are you looking to further develop your career and network with peers? Join the Center for Leading Innovation and Collaboration (CLIC) Career Development Community!

We are excited to host you at the 4th Annual Children's National - NIAID Symposium! This annual symposium celebrates the partnership between Children’s National Hospital (CNH) and the National Institute of Allergy and Infectious Diseases (NIAID). Established in 2017, the CNH-NIAID partnership focuses on advancing the health of children with allergic, immunologic, and infectious diseases through collaborative research and education.

The National Institutes of Health’s new ACTIV-6 trial will use #DrugRepurposing to test several existing drugs to determine whether they provide safe, effective symptom relief for mild to moderate #COVID19 symptoms at home.